NASDAQ: IRIX - IRIDEX Corporation

Altı ay boyunca karlılık: -16.92%
Sektör: Healthcare

Promosyon programı IRIDEX Corporation


Şirket hakkında

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology.

daha fazla ayrıntı
It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

EBITDA -0.0083
EV/EBITDA -2.6
IPO date 1996-02-15
ISIN US4626841013
Industry Health Care Equipment & Supplies
P/BV 1.36
P/S 0.713
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка 0.0434
Сайт https://www.iridex.com
Цена ао 2.51
Число акций ао 0.01613 млрд
Günlük fiyat değişimi: 0% (1.67)
Haftalık fiyat değişimi: +1.83% (1.64)
Aylık fiyat değişimi: -7.22% (1.8)
3 ayda fiyat değişimi: -6.7% (1.79)
Altı ayda fiyat değişimi: -16.92% (2.01)
Yıllık fiyat değişimi: -40.57% (2.81)
3 yılda fiyat değişimi: -70.49% (5.66)
5 yılda fiyat değişimi: -29.24% (2.36)
10 yılda fiyat değişimi: 0% (1.67)
Yılbaşından bu yana fiyat değişimi: -2.05% (1.705)

Hafife alma

İsim Anlam Seviye
P/S 0.8084 9
P/BV 4.4 4
P/E 0 0
EV/EBITDA -4.72 0
Toplam: 5.13

Yeterlik

İsim Anlam Seviye
ROA, % -27.79 0
ROE, % -100.5 0
Toplam: 0

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA -0.3443 10
Toplam: 9.8

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 19.51 3
karlılık Ebitda, % -11.39 0
karlılık EPS, % -7.72 0
Toplam: 1

ETF Paylaşmak, % Yıllık karlılık, % Temettüler, %
iShares Micro-Cap ETF 0.00705 13.79 1.54048
Dimensional U.S. Core Equity 2 ETF 0.00005 30.76 1.47098



Süpervizör İş unvanı Ödeme Doğum yılı
Mr. David I. Bruce CEO & Director 397.19k 1959 (66 yıllar)
Mr. Fuad Ahmad Interim Chief Financial Officer 356.83k 1970 (55 yıllar)
Mr. Patrick Mercer President & COO 365.85k 1972 (53 yıl)
Ms. Leigh Salvo Head of Investor Relations N/A

Adres: United States, Mountain View. CA, 1212 Terra Bella Avenue - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.iridex.com